Skip to main content
. 2007 May;121(1):40–50. doi: 10.1111/j.1365-2567.2007.02535.x

Table 3.

C1 activation by different CRP forms

Activation %
nCRP (100 μg/ml) 9·3%
uCRP (100 μg/ml) 20·4%
nCRP (100 μg/ml) + PC-Sepharose1 23·9%
Cr-mCRP (100 μg/ml) 47·6%
1

No significant C1 activation was observed using PC-Sepharose alone as a control.

HHS Vulnerability Disclosure